Top compounds associated with response to CHRD


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.092 0.02
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.02
mRNA YM-155 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.083 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.082 0.02
mRNA bid1870 gCSI pan-cancer AAC -0.13 0.02
mRNA Panobinostat CTRPv2 pan-cancer AAC 0.075 0.02
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.08 0.03
Download CSV